Cargando…

Exploratory Investigation of Bacteroides fragilis Transcriptional Response during In vitro Exposure to Subinhibitory Concentration of Metronidazole

Bacteroides fragilis, member from commensal gut microbiota, is an important pathogen associated to endogenous infections and metronidazole remains a valuable antibiotic for the treatment of these infections, although bacterial resistance is widely reported. Considering the need of a better understan...

Descripción completa

Detalles Bibliográficos
Autores principales: de Freitas, Michele C. R., Resende, Juliana A., Ferreira-Machado, Alessandra B., Saji, Guadalupe D. R. Q., de Vasconcelos, Ana T. R., da Silva, Vânia L., Nicolás, Marisa F., Diniz, Cláudio G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028390/
https://www.ncbi.nlm.nih.gov/pubmed/27703449
http://dx.doi.org/10.3389/fmicb.2016.01465
_version_ 1782454361233817600
author de Freitas, Michele C. R.
Resende, Juliana A.
Ferreira-Machado, Alessandra B.
Saji, Guadalupe D. R. Q.
de Vasconcelos, Ana T. R.
da Silva, Vânia L.
Nicolás, Marisa F.
Diniz, Cláudio G.
author_facet de Freitas, Michele C. R.
Resende, Juliana A.
Ferreira-Machado, Alessandra B.
Saji, Guadalupe D. R. Q.
de Vasconcelos, Ana T. R.
da Silva, Vânia L.
Nicolás, Marisa F.
Diniz, Cláudio G.
author_sort de Freitas, Michele C. R.
collection PubMed
description Bacteroides fragilis, member from commensal gut microbiota, is an important pathogen associated to endogenous infections and metronidazole remains a valuable antibiotic for the treatment of these infections, although bacterial resistance is widely reported. Considering the need of a better understanding on the global mechanisms by which B. fragilis survive upon metronidazole exposure, we performed a RNA-seq transcriptomic approach with validation of gene expression results by qPCR. Bacteria strains were selected after in vitro subcultures with subinhibitory concentration (SIC) of the drug. From a wild type B. fragilis ATCC 43859 four derivative strains were selected: first and fourth subcultures under metronidazole exposure and first and fourth subcultures after drug removal. According to global gene expression analysis, 2,146 protein coding genes were identified, of which a total of 1,618 (77%) were assigned to a Gene Ontology term (GO), indicating that most known cellular functions were taken. Among these 2,146 protein coding genes, 377 were shared among all strains, suggesting that they are critical for B. fragilis survival. In order to identify distinct expression patterns, we also performed a K-means clustering analysis set to 15 groups. This analysis allowed us to detect the major activated or repressed genes encoding for enzymes which act in several metabolic pathways involved in metronidazole response such as drug activation, defense mechanisms against superoxide ions, high expression level of multidrug efflux pumps, and DNA repair. The strains collected after metronidazole removal were functionally more similar to those cultured under drug pressure, reinforcing that drug-exposure lead to drastic persistent changes in the B. fragilis gene expression patterns. These results may help to elucidate B. fragilis response during metronidazole exposure, mainly at SIC, contributing with information about bacterial survival strategies under stress conditions in their environment.
format Online
Article
Text
id pubmed-5028390
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-50283902016-10-04 Exploratory Investigation of Bacteroides fragilis Transcriptional Response during In vitro Exposure to Subinhibitory Concentration of Metronidazole de Freitas, Michele C. R. Resende, Juliana A. Ferreira-Machado, Alessandra B. Saji, Guadalupe D. R. Q. de Vasconcelos, Ana T. R. da Silva, Vânia L. Nicolás, Marisa F. Diniz, Cláudio G. Front Microbiol Microbiology Bacteroides fragilis, member from commensal gut microbiota, is an important pathogen associated to endogenous infections and metronidazole remains a valuable antibiotic for the treatment of these infections, although bacterial resistance is widely reported. Considering the need of a better understanding on the global mechanisms by which B. fragilis survive upon metronidazole exposure, we performed a RNA-seq transcriptomic approach with validation of gene expression results by qPCR. Bacteria strains were selected after in vitro subcultures with subinhibitory concentration (SIC) of the drug. From a wild type B. fragilis ATCC 43859 four derivative strains were selected: first and fourth subcultures under metronidazole exposure and first and fourth subcultures after drug removal. According to global gene expression analysis, 2,146 protein coding genes were identified, of which a total of 1,618 (77%) were assigned to a Gene Ontology term (GO), indicating that most known cellular functions were taken. Among these 2,146 protein coding genes, 377 were shared among all strains, suggesting that they are critical for B. fragilis survival. In order to identify distinct expression patterns, we also performed a K-means clustering analysis set to 15 groups. This analysis allowed us to detect the major activated or repressed genes encoding for enzymes which act in several metabolic pathways involved in metronidazole response such as drug activation, defense mechanisms against superoxide ions, high expression level of multidrug efflux pumps, and DNA repair. The strains collected after metronidazole removal were functionally more similar to those cultured under drug pressure, reinforcing that drug-exposure lead to drastic persistent changes in the B. fragilis gene expression patterns. These results may help to elucidate B. fragilis response during metronidazole exposure, mainly at SIC, contributing with information about bacterial survival strategies under stress conditions in their environment. Frontiers Media S.A. 2016-09-20 /pmc/articles/PMC5028390/ /pubmed/27703449 http://dx.doi.org/10.3389/fmicb.2016.01465 Text en Copyright © 2016 de Freitas, Resende, Ferreira-Machado, Saji, de Vasconcelos, da Silva, Nicolás and Diniz. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
de Freitas, Michele C. R.
Resende, Juliana A.
Ferreira-Machado, Alessandra B.
Saji, Guadalupe D. R. Q.
de Vasconcelos, Ana T. R.
da Silva, Vânia L.
Nicolás, Marisa F.
Diniz, Cláudio G.
Exploratory Investigation of Bacteroides fragilis Transcriptional Response during In vitro Exposure to Subinhibitory Concentration of Metronidazole
title Exploratory Investigation of Bacteroides fragilis Transcriptional Response during In vitro Exposure to Subinhibitory Concentration of Metronidazole
title_full Exploratory Investigation of Bacteroides fragilis Transcriptional Response during In vitro Exposure to Subinhibitory Concentration of Metronidazole
title_fullStr Exploratory Investigation of Bacteroides fragilis Transcriptional Response during In vitro Exposure to Subinhibitory Concentration of Metronidazole
title_full_unstemmed Exploratory Investigation of Bacteroides fragilis Transcriptional Response during In vitro Exposure to Subinhibitory Concentration of Metronidazole
title_short Exploratory Investigation of Bacteroides fragilis Transcriptional Response during In vitro Exposure to Subinhibitory Concentration of Metronidazole
title_sort exploratory investigation of bacteroides fragilis transcriptional response during in vitro exposure to subinhibitory concentration of metronidazole
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028390/
https://www.ncbi.nlm.nih.gov/pubmed/27703449
http://dx.doi.org/10.3389/fmicb.2016.01465
work_keys_str_mv AT defreitasmichelecr exploratoryinvestigationofbacteroidesfragilistranscriptionalresponseduringinvitroexposuretosubinhibitoryconcentrationofmetronidazole
AT resendejulianaa exploratoryinvestigationofbacteroidesfragilistranscriptionalresponseduringinvitroexposuretosubinhibitoryconcentrationofmetronidazole
AT ferreiramachadoalessandrab exploratoryinvestigationofbacteroidesfragilistranscriptionalresponseduringinvitroexposuretosubinhibitoryconcentrationofmetronidazole
AT sajiguadalupedrq exploratoryinvestigationofbacteroidesfragilistranscriptionalresponseduringinvitroexposuretosubinhibitoryconcentrationofmetronidazole
AT devasconcelosanatr exploratoryinvestigationofbacteroidesfragilistranscriptionalresponseduringinvitroexposuretosubinhibitoryconcentrationofmetronidazole
AT dasilvavanial exploratoryinvestigationofbacteroidesfragilistranscriptionalresponseduringinvitroexposuretosubinhibitoryconcentrationofmetronidazole
AT nicolasmarisaf exploratoryinvestigationofbacteroidesfragilistranscriptionalresponseduringinvitroexposuretosubinhibitoryconcentrationofmetronidazole
AT dinizclaudiog exploratoryinvestigationofbacteroidesfragilistranscriptionalresponseduringinvitroexposuretosubinhibitoryconcentrationofmetronidazole